Jeong Hyun Lee

Jeong Hyun Lee

Auto-generated profile, based on publicly available information

Jeong Hyun Lee

Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
EHEun Ju Ha
Eun Ju Ha
SCSae Rom Chung
Sae Rom Chung
DNDong Gyu Na
Dong Gyu Na
HAHye Shin Ahn
Hye Shin Ahn
JCJin Chung
Jin Chung
MCMiyoung Choi
Miyoung Choi
Ha EJ, et al. Korean J Radiol. 2021 Dec;22(12):2094-2123. https://doi.org/10.3348/kjr.2021.0713

27 October 2016 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
Chong Hyun SuhChong Hyun Suh
Chong Hyun Suh
JBJung Hwan Baek
Jung Hwan Baek
YCY.J. Choi
Y.J. Choi
JLJ.H. Lee
J.H. Lee
BACKGROUND AND PURPOSE: Ultrasound has become widely accepted as the first imaging technique used for the assessment of cervical lymph node metastasis in patients with papillary thyroid cancer. In this systematic review and meta-analysis, we evaluate the performance of CT for the preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid cancer compared with ultrasound. MATERIALS AND METHODS: Ovid-MEDLINE and EMBASE data bases were searched for studies regarding the use of CT to diagnose cervical lymph node metastasis. The diagnostic performance of CT, ultrasound, and combined CT/ultrasound was assessed by using level-by-level and patient-based analyses. We also performed meta-analyses on the basis of the central and lateral neck levels. RESULTS: Nine eligible studies, including a total sample size of 1691 patients, were included. CT showed a summary sensitivity of 62% (95% CI, 52%–70%) and specificity of 87% (95% CI, 80%–92%) for diagnosing cervical lymph node metastasis when using level-by-level analysis. There was a positive correlation between the sensitivity and the false-positive rate (correlation coefficient, 0.807) because of the threshold effect. The summary sensitivity of combined CT/ultrasound (69%; 95% CI, 61%–77%) was significantly higher than ultrasound (51%; 95% CI, 42%–60%), though the summary specificity did not differ. CONCLUSIONS: The diagnostic performances of CT and ultrasound are similar, though CT and ultrasound combined are superior to ultrasound only. CT may be used as a complementary diagnostic method in addition to ultrasound for diagnosing cervical lymph node metastasis in patients with papillary thyroid cancer.

10 February 2015 in Ultrasonography
Verified
Journal Article
Open access
PDF file
YCYoung Jun Choi
Young Jun Choi
JLJeong Hyun Lee
Jeong Hyun Lee
JBJung Hwan Baek
Jung Hwan Baek
Ultrasound (US) elastography has been introduced as a noninvasive imaging technique for evaluating cervical lymph nodes. US elastography techniques include strain elastography and shear wave-based elastography. The application of this technique is based on the fact that stiff tissues tend to deform less and show less strain than compliant tissues when the same force is applied. In general, metastatic lymph nodes demonstrate higher stiffness than benign lymph nodes. Overall, preliminary studies suggest that US elastography may be useful in differentiating benign and malignant cervical lymph nodes, thereby informing decisions to perform a biopsy and facilitating follow-up. For US elastography to be accepted into clinical practice, however, its techniques, associated diagnostic criteria, and reliability need to be further refined.

1 January 2007 in American Journal of Roentgenology
Verified
Journal Article
Closed access
JLJeong Hyun Lee
Jeong Hyun Lee
HLHo Kyu Lee
Ho Kyu Lee
DLDeok Hee Lee
Deok Hee Lee
CCChoong Gon Choi
Choong Gon Choi
SKSang Joon Kim
Sang Joon Kim
DSDae Chul Suh
Dae Chul Suh
OBJECTIVE. The purposes of this study were to review the anatomy of the oculosympathetic pathway, to describe the clinical characteristics of the three types of Horner syndrome, and to illustrate underlying pathologic features with an emphasis on neuroimaging strategies based on three symptom complexes.CONCLUSION. Horner syndrome results from interruption of the oculosympathetic pathway and is usually associated with unique clinical features classified into central, preganglionic, and postganglionic types according to the anatomic location of the underlying pathologic process.

14 January 2019 in International Journal of Hyperthermia
Verified
Journal Article
Open access
SCSae Rom Chung
Sae Rom Chung
JBJung Hwan Baek
Jung Hwan Baek
YCYoung Jun Choi
Young Jun Choi
JLJeong Hyun Lee
Jeong Hyun Lee
Objective: The aim of this study was to introduce a management strategy for nerve damage occurring during radiofrequency ablation (RFA). Methods: From January 2016 to October 2017, 17 patients who experienced the symptoms of nerve damage during RFA were enrolled in this study. If damage to nerves was suspected during RFA, ablation was stopped immediately, and a cold solution of 5% dextrose was injected directly into the space where the nerves were located until symptoms improved. Patients were followed up after the procedure until symptoms had resolved. The clinical data of patients who received a cold dextrose solution injection for nerve damage were compared with those who did not receive such an injection. Results: Of 17 patients who experienced nerve damage, 12 received an injection of cold dextrose solution shortly after the emergence of symptoms. While resolution of symptoms was seen in all 17 patients, the mean time to recovery was significantly faster in the 12 patients who received treatment with an injection of cold dextrose solution than in those patients who did not receive such a treatment (p value = .041). Conclusions: In the event of thermal damage to adjacent nerve structures during RFA, the direct injection of a cold dextrose solution is a simple and effective treatment that can result in rapid symptom resolution.

7 August 2020 in Thyroid®
Verified
Journal Article
Closed access
PKPyeong Hwa Kim
Pyeong Hwa Kim
Chong Hyun SuhChong Hyun Suh
Chong Hyun Suh
JBJung Hwan Baek
Jung Hwan Baek
SCSae Rom Chung
Sae Rom Chung
YCYoung Jun Choi
Young Jun Choi
JLJeong Hyun Lee
Jeong Hyun Lee
Background: Several ultrasound (US)-based risk stratification systems have been increasingly used for the optimal management of thyroid nodules. However, there are considerable discrepancies across these systems. This study aimed to summarize and compare the category-based diagnostic performance in the detection of thyroid cancer of different US-based risk stratification systems from four societies: the American College of Radiology-Thyroid Imaging Reporting and Data System (ACR-TIRADS), the American Thyroid Association (ATA), the Korean Thyroid Association/Korean Society of Thyroid Radiology (KTA/KSThR; K-TIRADS), and the European Thyroid Association (EU-TIRADS). Methods: MEDLINE/PubMed and EMBASE databases were searched to identify original articles investigating the category-based diagnostic performance according to at least one of the following guidelines: ACR-TIRADS, ATA, K-TIRADS, and EU-TIRADS. Pooled sensitivity and specificity were calculated using a bivariate random-effects model. A subgroup analysis on nodules of 1 cm or larger and a meta-regression analysis to identify factors associated with the diagnostic performance were performed. Results: A total of 29 articles including 33,748 thyroid nodules met the eligibility criteria and were included in the analysis. For ACR-TIRADS, the pooled sensitivity and specificity were, respectively, 66% and 91% for category 5 and 95% and 55% for category 4 or 5. For ATA, the pooled sensitivity and specificity were, respectively, 74% and 88% for category 5 and 91% and 64% for category 4 or 5. For K-TIRADS, the pooled sensitivity and specificity were, respectively, 55% and 95% for category 5 and 89% and 64% for category 4 or 5. For EU-TIRADS, the pooled sensitivity and specificity were, respectively, 82% and 90% for category 5 and 96% and 52% for category 4 or 5. Study location, proportion of female patients and malignant nodules, and study design were associated with study heterogeneity. Conclusions: The overall diagnostic performance of the four US-based risk stratification systems was comparable.